These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15163493)

  • 21. Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.
    Hurt AC; McKimm-Breschkin JL; McDonald M; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):205-11. PubMed ID: 15163511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
    Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
    Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virology. The origin and control of pandemic influenza.
    Laver G; Garman E
    Science; 2001 Sep; 293(5536):1776-7. PubMed ID: 11546857
    [No Abstract]   [Full Text] [Related]  

  • 29. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.
    Blick TJ; Tiong T; Sahasrabudhe A; Varghese JN; Colman PM; Hart GJ; Bethell RC; McKimm-Breschkin JL
    Virology; 1995 Dec; 214(2):475-84. PubMed ID: 8553549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.
    Abed Y; Goyette N; Boivin G
    Antivir Ther; 2004 Aug; 9(4):577-81. PubMed ID: 15456089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
    Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
    J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S; Schweiger B
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
    Lange W; Vogel GE
    MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir.
    Wang MZ; Tai CY; Mendel DB
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3809-16. PubMed ID: 12435681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.
    McKimm-Breschkin J; Trivedi T; Hampson A; Hay A; Klimov A; Tashiro M; Hayden F; Zambon M
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2264-72. PubMed ID: 12821478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase inhibitors for treatment of influenza.
    Ebell MH
    Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
    Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
    Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.